Splenic fluorodeoxyglucose uptake increased by granulocyte colony- stimulating factor therapy: PET imaging results

Journal of Nuclear Medicine

Volumn 40, Issue 9, 1999, Pages 1456-1462

  Sugawara, Yoshifumi ^a   Zasadny, Kenneth R ^a   Kison, Paul V ^a   Baker, Laurence H ^a   Wahl, Richard L ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Breast cancer; Fluorodeoxyglucose; Granulocyte colony stimulating factor; PET; Spleen

Indexed keywords

FLUORODEOXYGLUCOSE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CORRELATION FUNCTION; DRUG MONITORING; FEMALE; HUMAN; IMAGE ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SPLEEN; TISSUE LEVEL;

ADULT; BREAST NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MIDDLE AGED; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SPLEEN; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032859524     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Groopman JE, Molina JM, Scadden DT. Hematopoietic growth factors. Biology and clinical applications. N Engl J Med. 1989;321:1449-1459.
2. Lieschke GJ, Burgess AW. Granulocyle colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1). N Engl J Med. 1992;327:28-35.
3. Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2). N Engl J Med. 1992;327:99-106.
4. Crawford J, Ozer H, Stoller R, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med. 1991;324:164-170.
5. Warburg O, Wind F, Niglers E. On the metabolism of tumors in the body. In: Warburg O, ed. Metabolism of Tumors. London, England: Constable: 1930:254-270.
6. Wahl RL. Positron emission tomography: application in oncology. In: Murray IPC, EII PJ, Strauss HW, eds. Nuclear Medicine in Clinical Diagnosis and Treatment. London, England: Churchill Livingstone; 1994:801-820.
7. Yao WJ, Hoh CK, Hawkins RA, et al. Quantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines. J Nucl Med. 1995;36:794-799.
8. Knopp MV, Bischoff H, Rimac A, Oberdorfer F, van Kaick G. Bone marrow uptake of fluorine-18-fluorodeoxyglucose following treatment with hematopoietic growth factors: initial evaluation. Nucl Med Biol. 1996;23:845-849.
9. Sugawara Y, Fisher SJ, Zasadny KR, Kison PV, Baker LH, Wahl RL. Preclinical and clinical studies of bone marrow uptake of fluorine-18-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy. J Clin Oncol. 1998;16:173-180.
10. Hollinger EF, Alibazoglu H, Ali A, Green A, Lamonica G. Hematopoietic cytokine-mediated FDG uptake stimulates the appearance of diffuse metastatic disease on whole-body PET imaging. Clin Nucl Med. 1998;23:93-98.
11. 18F]fluoro-D-glucose by direct nucleophilic exchange on a quatenary 4-aminopyridinium resin. Int J Rad Appl Instrum [B]. 1990;17:273-279.
12. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology. 1993;189:847-850.
13. Wahl RL, Zasadny K, Helvie M, Hutchins GD, Weber B, Cody R. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol. 1993;11:2101-2111.
14. Fletcher BD, Wall JE, Hanna SL. Effect of hematopoietic growth factors on MR images of bone marrow in children undergoing chemotherapy. Radiology. 1993;189:745-751.
15. Abdel-Dayem HM, Sanchez J, al-Mohannadi S, Kempf J. Diffuse thallium-201-chloride uptake in hypermetabolic bone marrow following treatment with granulocyte stimulating factor. J Nucl Med. 1992;33:2014-2016.
16. 99mTc-sulphur colloid during granulocyte colony-stimulating factor administration in autologous bone marrow transplantation. Nucl Med Commun. 1993;14:896-901.
17. Stokkel MP, Valdes Olmos RA, Hoefnagel CA, Richel DJ. Tumor and therapy associated abnormal changes on bone scintigraphy. Old and new phenomena. Clin Nucl Med. 1993;18:821-828.
18. Glaspy JA, Golde DW. Granulocyte colony-stimulating factor (G-CSF): preclinical and clinical studies. Semin Oncol. 1992;19:386-394.
19. Litam PP, Friedman HD, Loughran TP Jr. Splenic extramedullary hematopoiesis in a patient receiving intermittently administered granulocyte colony-stimulating factor. Ann Int Med. 1993;118:954-955.
20. Tsoi WC, To KF, Feng CS. Splenic hematopoiesis after granulocyte-colony stimulating factor therapy in a lupus patient [letter]. Am J Hematol. 1996;53:283-284.
21. Wahl RL, Cody RL, Fisher SJ. FDG uptake before and after estrogen receptor stimulation: feasibility studies for functional receptor imaging [abstract]. J Nucl Med. 1991;32:1011.
22. 67Ga scintigraphy. Clin Nucl Med. 1995;20:250-253.